Skandinaviska Enskilda Banken AB publ raised its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 113.8% during the third quarter, HoldingsChannel.com reports. The fund owned 282,958 shares of the conglomerate’s stock after purchasing an additional 150,613 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Danaher were worth $56,099,000 at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of DHR. White Pine Capital LLC boosted its stake in shares of Danaher by 1.4% in the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock valued at $690,000 after purchasing an additional 49 shares in the last quarter. SOL Capital Management CO lifted its stake in Danaher by 2.8% in the 3rd quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock valued at $363,000 after purchasing an additional 50 shares during the last quarter. Purkiss Capital Advisors LLC lifted its stake in Danaher by 3.9% in the 3rd quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock valued at $263,000 after purchasing an additional 50 shares during the last quarter. Boyd Watterson Asset Management LLC OH boosted its position in Danaher by 2.1% in the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock valued at $499,000 after buying an additional 51 shares in the last quarter. Finally, TCTC Holdings LLC grew its stake in shares of Danaher by 0.7% during the third quarter. TCTC Holdings LLC now owns 7,439 shares of the conglomerate’s stock worth $1,475,000 after buying an additional 51 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Stock Down 1.2%
Shares of NYSE DHR opened at $212.37 on Tuesday. The company’s 50 day moving average price is $228.40 and its 200-day moving average price is $215.71. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The company has a market capitalization of $150.01 billion, a P/E ratio of 42.14, a price-to-earnings-growth ratio of 2.87 and a beta of 0.91.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio is presently 25.40%.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on DHR shares. Barclays raised their price objective on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Argus set a $265.00 price objective on shares of Danaher in a report on Wednesday, January 14th. Finally, Leerink Partners boosted their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $253.86.
Get Our Latest Research Report on DHR
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
